Krish S. Krishnan
CIK: 0001298709
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Krystal Biotech, Inc.
Discretionary Trading P&L
Holdings
Transaction History (134 total)
- Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct4K shares at avg. $357.57$1.4M - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct2K shares at avg. $362.65$729K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct2.3K shares at avg. $360.46$817K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct520 shares at avg. $354.54$184K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct405 shares at avg. $366.56$148K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct3.1K shares at avg. $358.42$1.1M - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct2K shares at avg. $355.57$721K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct3.3K shares at avg. $356.37$1.2M - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct1.2K shares at avg. $361.61$439K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct3.4K shares at avg. $359.39$1.2M - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct1.4K shares at avg. $364.48$495K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct573 shares at avg. $363.34$208K - Sep 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct847 shares at avg. $365.42$310K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct320 shares at avg. $300.75$96K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct640 shares at avg. $302.24$193K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct176 shares at avg. $303.17$53K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct964 shares at avg. $311.36$300K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct40 shares at avg. $312.23$12K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct2.8K shares at avg. $309.49$862K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct11.5K shares at avg. $307.68$3.5M - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct544 shares at avg. $304.81$166K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct2.7K shares at avg. $310.43$823K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct589 shares at avg. $306.33$180K - Jun 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct4.8K shares at avg. $308.47$1.5M - Mar 4, 2026KRYS
Krystal Biotech, Inc.
Sale(S)Direct920 shares at avg. $266.56$245K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,981 | $357.57 | $1,423,501 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,010 | $362.65 | $728,927 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,266 | $360.46 | $816,809 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 520 | $354.54 | $184,361 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 405 | $366.56 | $148,455 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,143 | $358.42 | $1,126,508 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,029 | $355.57 | $721,455 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,297 | $356.37 | $1,174,948 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 1,214 | $361.61 | $438,993 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 3,357 | $359.39 | $1,206,459 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 1,358 | $364.48 | $494,963 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 573 | $363.34 | $208,195 | Direct |
| Sep 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 847 | $365.42 | $309,508 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 320 | $300.75 | $96,240 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 640 | $302.24 | $193,431 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 176 | $303.17 | $53,358 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 964 | $311.36 | $300,149 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 40 | $312.23 | $12,489 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,784 | $309.49 | $861,620 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 11,461 | $307.68 | $3,526,293 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 544 | $304.81 | $165,817 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 2,652 | $310.43 | $823,258 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 589 | $306.33 | $180,429 | Direct |
| Jun 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 4,830 | $308.47 | $1,489,899 | Direct |
| Mar 4, 2026 | KRYS Krystal Biotech, Inc. | Sale(S) | 920 | $266.56 | $245,231 | Direct |
1-25 of 134 transactions
About Krishnan Krish S
Krishnan Krish S (SEC CIK 0001298709) files insider reports with the SEC as President and CEO of Krystal Biotech, Inc. (KRYS).
Signal8 holds 11 ownership filings by Krishnan Krish S, all Form 4s, filed between Sep 13, 2024 and Sep 4, 2026. Those filings report 134 transactions, from Sep 12, 2024 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Krishnan Krish S's filings is in PITTSBURGH, PA.
Recent filings by Krishnan Krish S
Other insiders filing for Krystal Biotech, Inc. (KRYS)
- ROSSI DINO A, Director
- Sutherland Everett Rand, Director
- Mazzacco Catherine, Director
- Mason Christopher, Director
- JANNEY DANIEL, Director
- Gangolli Julian S, Director